Maternus-Kliniken Aktiengesellschaft (MAK) Fair Value & Analysis
Healthcare · DE · Market cap €21.2M
Fair value as of: Jun 25, 2026
From 12 valuation models · updated 4 days ago
Share price −6.9% over the past month.
Price vs Fair Value (12 months)
12‑month range €0.7755 – €4.06 · fair‑value band €2.28 – €3.32 · the €0.9000 price screens below the €2.28 fair value. As of Jun 25, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Maternus-Kliniken Aktiengesellschaft (MAK) currently trades at €0.9000, while our model-based Fair Value estimate is €2.28 — implying the stock looks roughly 153.3% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, Maternus-Kliniken Aktiengesellschaft generated revenue of €118M at a net margin of -11.7%. Revenue grew 3.3% year over year. Net debt stands at €119M. Fundamentals as of Jun 25, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 25, 2026. TTM = trailing twelve months.
About the company
Maternus-Kliniken Aktiengesellschaft operates retirement and nursing homes in Germany. The company offers senior living and care facilities, rehabilitation clinics, and specialized services in geriatric care and rehabilitation medicine. It also provides emergency call, assisted living, and follow-up treatment services, as well as fully inpatient care, outpatient care, and home emergency call services. Maternus-Kliniken Aktiengesellschaft was founded in 1877 and is headquartered in Berlin, Germany.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Maternus-Kliniken Aktiengesellschaft reported revenue of €118M in FY2025 versus €111M in FY2021, a compound +1.4%/yr. Reported net income was −€13.9M in FY2025.
Open the full interactive analysis →
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jun 25, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$95.75 | R$123.65 | +29% |
| Fresenius SE FSNUY | $11.27 | $8.25 | -27% |
| 5225 5225 | 8.70 MYR | 2.61 MYR | -70% |
| IHHHF IHHHF | $1.71 | $1.26 | -26% |
| Tenet Healthcare Corporation THC | $162.06 | $282.55 | +74% |
| Rede D'Or São Luiz S.A RDOR3 | R$32.76 | R$30.33 | -7% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Maternus-Kliniken Aktiengesellschaft (MAK) undervalued?
What is the fair value of MAK?
What is the quality score of MAK?
What is the revenue of Maternus-Kliniken Aktiengesellschaft (MAK)?
What is the net profit margin of MAK?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.